BOLD vs NKE · P/E 0.1, $24.6M cap vs P/E 35, rev $46.31B
Boundless Bio, Inc. Common Stock (BOLD) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
BOLD does not have a complete income-statement cache yet.
Latest reported NKE revenue for 2025-05-31 was $46.31B. Net income was $3.22B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the BOLD and NKE stock pages for the full models.
Not investment advice.